Cardiac Amyloidosis Treatment

Cardiac amyloidosis (CA) is a restrictive cardiomyopathy with a traditionally poor prognosis. Until recently, CA treatment options were limited and consisted predominantly of managing symptoms and disease-related complications. However, the last decade has seen significant advances in disease-modify...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Lily K., Patel, Jignesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Houston Methodist DeBakey Heart & Vascular Center 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932359/
https://www.ncbi.nlm.nih.gov/pubmed/35414852
http://dx.doi.org/10.14797/mdcvj.1050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932359/
https://www.ncbi.nlm.nih.gov/pubmed/35414852
http://dx.doi.org/10.14797/mdcvj.1050

Ejemplares similares